Publications
Found 4 results
Filters: Author is L.C. Mattos [Clear All Filters]
, ,
“Lack of association of the G22A polymorphism of the ADA gene in patients with ankylosing spondylitis”, vol. 11, pp. 1178-1184, 2012.
, Bottini E, Carapella E, Cataldi L, Nicotra M, et al. (1981). Adenosine deaminase polymorphism. Associations at clinical level suggest a role in cell functions and immune reactions. J. Med. Genet. 18: 331-334.
http://dx.doi.org/10.1136/jmg.18.5.331
PMid:7199090 PMCid:1048752
Breban M (2006). Genetics of spondyloarthritis. Best Pract. Res. Clin. Rheumatol. 20: 593-599.
http://dx.doi.org/10.1016/j.berh.2006.03.002
PMid:16777584
Brionez TF and Reveille JD (2008). The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis. Curr. Opin. Rheumatol. 20: 384-391.
http://dx.doi.org/10.1097/BOR.0b013e32830460fe
PMid:18525349
Dutra GP, Ottoni GL, Lara DR and Bogo MR (2010). Lower frequency of the low activity adenosine deaminase allelic variant (ADA1*2) in schizophrenic patients. Rev. Bras. Psiquiatr. 32: 275-278.
http://dx.doi.org/10.1590/S1516-44462010005000003
PMid:20414589
Goie HS, Steven MM, Van der Linden SM and Cats A (1985). Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Rheumatology 24: 242-249.
http://dx.doi.org/10.1093/rheumatology/24.3.242
Hirschhorn R, Yang DR and Israni A (1994). An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover. Ann. Hum. Genet. 58: 1-9.
http://dx.doi.org/10.1111/j.1469-1809.1994.tb00720.x
PMid:8031011
Lima I, Néri F and Santiago MB (2005). Dosagem sérica de adenosina deaminase em lúpus eritematoso sistêmico: ausência de associação com atividade da doença. Rev. Bras. Reumatol. 45: 273-279.
http://dx.doi.org/10.1590/S0482-50042005000500002
Liu Y, Saccucci P, Qi H, Wu HC, et al. (2006). ADA polymorphisms and asthma: a study in the Chinese Han population. J. Asthma 43: 203-206.
http://dx.doi.org/10.1080/02770900600566827
PMid:16754522
Lopez de Castro JA (2007). HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol. Lett. 108: 27-33.
http://dx.doi.org/10.1016/j.imlet.2006.10.004
PMid:17129613
Nunes DP, Spegiorin LC, de Mattos CC, Oliani AH, et al. (2011). The ADA*2 allele of the adenosine deaminase gene (20q13.11) and recurrent spontaneous abortions: an age-dependent association. Clinics 66: 1929-1933.
http://dx.doi.org/10.1590/S1807-59322011001100013
PMid:22086524 PMCid:3203966
Saccucci P, Manca Bitti ML, Bottini N, Rapini N, et al. (2009). Type 1 diabetes: evidence of interaction between ACP1 and ADA1 gene polymorphisms. Med. Sci. Monit. 15: CR511-CR517.
PMid:19789510
Saccucci P, Meloni GF, Verrotti A, Borgiani P, et al. (2010). A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 23: 283-290.
http://dx.doi.org/10.1515/JPEM.2010.23.3.283
PMid:20480728
Safranow K, Rzeuski R, Binczak-Kuleta A, Czyzycka E, et al. (2007). ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease. Cardiology 108: 275-281.
http://dx.doi.org/10.1159/000099096
PMid:17287605
Sampaio-Barros PD, Azevedo VF, Bonfiglioli R, Campos WR, et al. (2007). Consenso Brasileiro de Espondiloartropatias: Espondilite Anquilosante e Artrite Psoriásica Diagnóstico e Tratamento - Primeira Revisão. Rev. Bras. Reumatol. 47: 233-242.
http://dx.doi.org/10.1590/S0482-50042007000400001
Sari RA, Taysi S, Yilmaz O and Bakan N (2003). Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin. Exp. Rheumatol. 21: 87-90.
PMid:12673895
Sasaki S (1984). Pathogenetic significance of adenosine deaminase in autoimmune diseases. Nihon Seikeigeka Gakkai Zasshi 58: 219-230.
PMid:6332160
SEADE (2009). Fundação Sistema Estadual de Análise de Dados. Secretaria de Planejamento e Desenvolvimento Regional. Perfil Regional. Região Administrativa de São José do Rio Preto. Available at [http://www.seade.gov.br/produtos/perfil_regional/index.php]. Accessed March 30, 2011.
Sebastiani GD, Bottini N, Greco E, Saccucci P, et al. (2010). A study of Adenosine-Deaminase genetic polymorphism in rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 23: 791-795.
PMid:20943049
Van der Linden S and Van der Heijde D (1998). Ankylosing spondylitis: clinical features. Rheum. Dis. Clin. North Am. 24: 663-676.
http://dx.doi.org/10.1016/S0889-857X(05)70036-3
Wessels JA, Kooloos WM, De Jonge R, De Vries-Bouwstra JK, et al. (2006). Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 54: 2830-2839.
http://dx.doi.org/10.1002/art.22032
PMid:16947783
“Comparison of oxidative stress and the frequency of polymorphisms in the HFE gene between hemoglobin S trait blood donors and sickle cell disease patients”, vol. 10, pp. 3446-3454, 2011.
,
Agostinho MF, Arruda VR, Basseres DS, Bordin S, et al. (1999). Mutation analysis of the HFE gene in Brazilian populations. Blood Cells Mol. Dis. 25: 324-327.
http://dx.doi.org/10.1006/bcmd.1999.0260
PMid:10660479
Bandeira FMGC, Bezerra MAC, Santos MNN and Gomes YM (2007). Importância dos programas de triagem para o gene da hemoglobina S. Rev. Bras. Hematol. Hemoter. 29: 179-184.
http://dx.doi.org/10.1590/S1516-84842007000200017
Beutler E (2004). Iron absorption in carriers of the C282Y hemochromatosis mutation. Am. J. Clin. Nutr. 80: 799-800.
PMid:15447883
Beutler E, Lichtman MA, Coller BS and Kipps TJ (1995). Williams Hematology. 5th edn. International Edition, New York.
Bittencourt PL, Palacios SA, Couto CA, Cancado EL, et al. (2002). Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis. Braz. J. Med. Biol. Res. 35: 329-335.
http://dx.doi.org/10.1590/S0100-879X2002000300007
PMid:11887210
Bonini-Domingos CR (2007). Aumento de ferro, hemocromatose hereditária e defeitos no gene HFE. O que conhecemos na população brasileira? Rev. Bras. Hematol. Hemoter. 29: 341-342.
http://dx.doi.org/10.1590/S1516-84842007000400003
Bonini-Domingos CR, Ondei LS and Zamaro PJA (2006). Hemoglobinas Similares a S no Brasil - Um Guia Prático de Identificação. 1ª ed. Editora HN, São José do Rio Preto.
Clegg JB and Weatherall DJ (1999). Thalassemia and malaria: new insights into an old problem. Proc. Assoc. Am. Physicians 111: 278-282.
http://dx.doi.org/10.1046/j.1525-1381.1999.99235.x
PMid:10417734
Cullen LM, Gao X, Easteal S and Jazwinska EC (1998). The hemochromatosis 845 G→A and 187 C→G mutations: prevalence in non-Caucasian populations. Am. J. Hum. Genet. 62: 1403-1407.
http://dx.doi.org/10.1086/301878
PMid:9585606 PMCid:1377157
de Souza AF, Carvalho-Filho RJ and Chebli JF (2001). Hereditary hemochromatosis. Case report and review of the literature. Arq. Gastroenterol. 38: 194-202.
http://dx.doi.org/10.1590/S0004-28032001000300010
PMid:11917720
Ferreira ACS, Oliveira VC, Caxito FA and Gomes KB (2008). Prevalence of C282Y and H63D mutations in the gene of Brazilian individuals with clinical suspicion of hereditary hemochromatosis. Rev. Bras. Hematol. Hemoter. 30: 379-383.
http://dx.doi.org/10.1590/S1516-84842008000500010
Fleming RE and Britton RS (2006). Iron Imports. VI. HFE and regulation of intestinal iron absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G590-G594.
http://dx.doi.org/10.1152/ajpgi.00486.2005
PMid:16537971
Frenette PS and Atweh GF (2007). Sickle cell disease: old discoveries, new concepts, and future promise. J. Clin. Invest. 117: 850-858.
http://dx.doi.org/10.1172/JCI30920
PMid:17404610 PMCid:1838946
Higgs DR and Weatherall DJ (1993). Thalassaemia. In: The Haemoglobinopathies (WB Saunders, ed.). Baillière's Clinical Hematology, London, 117.
Jeng MR, Adams-Graves P, Howard TA, Whorton MR, et al. (2003). Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease. Am. J. Hematol. 74: 243-248.
http://dx.doi.org/10.1002/ajh.10426
PMid:14635204
Naoum PC and Souza PC (2004). Avaliação dos produtos da degradação oxidativa da Hb S nos genótipos SS, SF (S/beta 0 talassemia) e AS, em comparação com hemoglobinas normais. Rev. Bras. Patol. Med. Lab. 40: 249-259.
http://dx.doi.org/10.1590/S1676-24442004000400007
Parra FC, Amado RC and Lambertucci JR (2003). Color and genomic ancestry in Brazilians. PNAS 100: 177-182.
http://dx.doi.org/10.1073/pnas.0126614100
PMid:12509516 PMCid:140919
Percário S (1999). Dosagem do Dialdeido Malônico. NEWSLAB, 46-50.
Pietrangelo A (2006). Hereditary hemochromatosis. Biochim. Biophys. Acta 1763: 700-710.
http://dx.doi.org/10.1016/j.bbamcr.2006.05.013
PMid:16891003
Powell LW (2002). Diagnosis of hemochromatosis. Semin. Gastrointest. Dis. 13: 80-88.
PMid:12064863
Re R, Pellegrini N, Proteggente A, Pannala A, et al. (1999). Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 26: 1231-1237.
http://dx.doi.org/10.1016/S0891-5849(98)00315-3
Serjeant GR (1992). Sickle Cell Disease. 2nd edn. Oxford University Press Inc., New York.
Siah CW, Ombiga J, Adams LA, Trinder D, et al. (2006). Normal iron metabolism and the pathophysiology of iron overload disorders. Clin. Biochem. Rev. 27: 5-16.
PMid:16886043 PMCid:1390789
Torres FR, Souza-Neiras WC, D'Almeida Couto AA, D'Almeida Couto VS, et al. (2008). Frequency of the HFE C282Y and H63D polymorphisms in Brazilian malaria patients and blood donors from the Amazon region. Genet. Mol. Res. 7: 60-64.
http://dx.doi.org/10.4238/vol7-1gmr408
PMid:18273820
Weatherall DJ and Clegg JB (2001). Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 79: 704-712.
PMid:11545326 PMCid:2566499